Nail toxicity related to weekly taxanes: An important issue requiring a change in common toxicity criteria grading? [3] (multiple letters)

Journal of Clinical Oncology

Volumn 20, Issue 21, 2002, Pages 4404-4405

  Spazzapan, Simon ^a   Crivellari, Diana ^a   Lombardi, Davide ^a   Scuderi, Cristina ^a   Magri, Maria Donatella ^a   Veronesi, Andrea ^a   Gatti, Alessandro ^a   Perez, Edith A ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; FLUOROURACIL; PACLITAXEL; TAXANE DERIVATIVE;

BLOOD TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG TOLERANCE; FATIGUE; HAND FOOT SYNDROME; HUMAN; LETTER; METASTASIS; NAIL BED; NAIL DISEASE; NEUROTOXICITY; ONYCHOLYSIS; PARONYCHIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE II; FEMALE; HUMANS; NAIL DISEASES; PACLITAXEL; PIGMENTATION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 0036842323     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.99.147     Document Type: Letter

References (0)